Craft

Charles River Laboratories

Stock Price

$221.6

2024-05-17

Market Capitalization

$11.4 B

2024-05-17

Revenue

$4.1 B

FY, 2023

Charles River Laboratories Summary

Company Summary

Overview
Charles River Laboratories International is a contract research organization (CRO) providing biotech research and development solutions. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment offers research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services, as well as controlled, consistent, customized primary cells and blood components derived from normal and mobilized peripheral blood, bone marrow, and cord blood. The DSA segment provides regulated and non-regulated DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing Solutions segment performs specialized testing of biologics, supplies fertile chicken eggs and chickens, and delivers in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceutical and consumer products.
Type
Public
Status
Active
Founded
1947
HQ
Wilmington, MA, US | view all locations
Website
https://www.criver.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • James C. Foster

    James C. Foster, Chairman, President & Chief Executive Officer

  • William D. Barbo

    William D. Barbo, Corporate Executive Vice President & Chief Commercial Officer

  • Joseph W. LaPlume

    Joseph W. LaPlume, Corporate Executive Vice President, Corporate Development & Strategy

  • Flavia Pease

    Flavia Pease, Corporate Executive Vice President & Chief Financial Officer

Operating MetricsView all

Backlog (Manufacturing)

$136M
71.7%

FY, 2021

Backlog (RMS)

$266M
58.7%

FY, 2021

Countries

20

FY, 2021

LocationsView all

93 locations detected

  • Wilmington, MA HQ

    United States

    251 Ballardvale St

  • Ashland, OH

    United States

    1407 George Rd

  • Charleston, SC

    United States

    1023 Wappoo Rd #43B

  • Chicago, IL

    United States

    Iit Tower, 10 W 35th St 8th Floor

  • Durham, NC

    United States

    4025 Stirrup Creek Dr #150

  • Frederick, MD

    United States

    8501 Progress Drive

and 87 others

Charles River Laboratories Financials

Summary Financials

Revenue (Q1, 2024)
$1.0B
Gross profit (Q1, 2024)
$344.8M
Net income (Q1, 2024)
$74.5M
Cash (Q1, 2024)
$327.0M
EBIT (Q1, 2024)
$126.0M
Enterprise value
$13.7B

Footer menu